Lack Of Internet Prescription Drug Sale Regulations Blamed For Low Profit Levels Of China's Online Pharmacies
This article was originally published in PharmAsia News
Executive SummaryChina currently has 15,000 pharmacy chains; six of the 30 companies licensed to conduct Internet drug sales are selling drugs online, but none have posted any profits so far, according to a Voice of China news report
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.